Cancer Research includes companies working on scientific research aimed at understanding the causes, prevention, diagnosis, treatment, and potential cures for cancer. It includes many disciplines, from biology and genetics, to clinical trials and drug development, with the ultimate goal of improving cancer care and outcomes. Cancer research companies are developing life-saving treatments and diagnostics for a growing market in high demand. These companies constantly innovate, have a global reach, and form important strategic partnerships, which makes them appealing to investors looking for profits and supporting health progress.
Arcus Biosciences In Collaboration With Gilead Sciences, Completes Patient Enrollment In Phase 3 Trial Evaluating A Domvanalimab-Containing Regimen In First-Line Metastatic Upper GI Cancers
Domvanalimab is the only anti-TIGIT antibody in Phase 3 for upper gastrointestinal (GI) adenocarcinomas with the potential to be first-to-market for this patient populationArcus Biosciences, Inc. (NYS
Nike, Merck, General Motors, And More: CNBC's 'Final Trades'
On CNBC's "Halftime Report Final Trades," Liz Young of SoFi named The Energy Select Sector SPDR Fund (NYSE:XLE) as her final trade.Jim Lebenthal of Cerity Partners said General Motors Company (NYSE:GM
The success of K drug cannot be replicated.
Merck CEO Robert Davis believes that the success of K drug cannot be replicated.
Lilly's Donanemeb, Remternetug Set to Dominate Alzheimer's Treatment by 2030
Bristol Myers Squibb Wins Antitrust Case Against Insurers Regarding Generics
GSK Wins FDA Nod to Expand Label for RSV Vaccine